VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 178 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,146,740 | -34.4% | 265,449 | 0.0% | 0.01% | -33.3% |
| Q2 2023 | $1,749,309 | +14.9% | 265,449 | +18.4% | 0.01% | +12.5% |
| Q1 2023 | $1,521,979 | -5.9% | 224,150 | +2.4% | 0.01% | -11.1% |
| Q4 2022 | $1,616,991 | +37.6% | 218,808 | +84.0% | 0.01% | +12.5% |
| Q3 2022 | $1,175,000 | +55.0% | 118,930 | +71.0% | 0.01% | +60.0% |
| Q2 2022 | $758,000 | +56.6% | 69,548 | +64.3% | 0.01% | +66.7% |
| Q2 2020 | $484,000 | +128.3% | 42,341 | +67.4% | 0.00% | +50.0% |
| Q1 2016 | $212,000 | -72.9% | 25,300 | -69.9% | 0.00% | -71.4% |
| Q4 2015 | $782,000 | -22.9% | 84,000 | -6.6% | 0.01% | -12.5% |
| Q3 2015 | $1,014,000 | +476.1% | 89,900 | +375.7% | 0.01% | +700.0% |
| Q1 2015 | $176,000 | -65.8% | 18,900 | -47.4% | 0.00% | -75.0% |
| Q4 2014 | $514,000 | -80.2% | 35,900 | -75.2% | 0.00% | -78.9% |
| Q1 2014 | $2,595,000 | – | 144,707 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |